+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Respiratory Care Devices Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 197 Pages
  • October 2025
  • Region: Global
  • 360iResearch™
  • ID: 5675118
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The global respiratory care devices market is driving significant changes in healthcare as leaders seek advanced solutions that align innovation, efficiency, and agility across diverse clinical environments. Strategic insights into this market help organizations respond to new operational priorities and shift toward integrated digital care models.

Market Snapshot: Respiratory Care Devices Market Overview

In 2024, the respiratory care devices market reached USD 22.53 billion, demonstrating robust expansion and innovation in support of healthcare transformation. The sector is on track to grow to USD 24.39 billion in 2025 and potentially reach USD 43.86 billion by 2032, propelled by a strong CAGR of 8.67%. This progress is propelled by rising demand for interoperable technologies, scalable solutions for remote care, and platforms designed to enable actionable insights and data-driven management. Healthcare organizations are increasingly investing in digital infrastructure that streamlines both centralized oversight and localized delivery, supporting improved patient engagement and operational efficiency.

Scope & Segmentation of the Respiratory Care Devices Market

This analysis provides senior decision-makers with actionable intelligence for investment and operational planning. The respiratory care devices market spans a broad set of technologies, user categories, and care environments. Complexities in care delivery require adaptable technologies and regional focus. Key market scope and segmentation highlights include:

  • Product Type: Includes devices for diagnosis, monitoring, therapy, consumables, and accessories, covering needs from acute interventions to long-term respiratory support.
  • Consumables & Accessories: Covers essential components such as breathing circuits, masks, nasal cannulas, and tracheostomy tubes—critical for infection control, patient comfort, and care continuity.
  • Diagnostic Devices: Integrates peak flow meters, sleep apnea monitors, and spirometers that enable early and precise assessment of respiratory function across care settings.
  • Monitoring Devices: Encompasses capnographs and pulse oximeters, offering real-time clinical data and supporting reliable decision-making for both onsite and remote care.
  • Therapeutic Devices: Delivers solutions including humidifiers, nebulizers, oxygen concentrators, and positive airway pressure systems, facilitating responses to acute and chronic respiratory needs.
  • Patient Group: Addresses a full spectrum of patient ages—adult, pediatric, neonatal, and geriatric—with products designed for specificity and compliance.
  • Indication: Supports interventions for acute respiratory distress, asthma, COPD, and sleep-disordered breathing through advanced device technologies and adaptable use cases.
  • Sales Channel: Offers flexible procurement via both online and offline channels to improve responsiveness as supply requirements change.
  • End User: Enables utilization in hospitals, clinics, ambulatory care, homecare, and diagnostic settings to support multipoint healthcare delivery and patient transitions.
  • Region: Analyzes development and adoption across the Americas, EMEA, and Asia-Pacific, examining local infrastructure, digital uptake, and regulatory factors shaping access to new technologies.
  • Leading Companies Analyzed: Evaluates strategies and industry roles of ResMed Corp., Baxter International, Philips, Medtronic, Teleflex, GE HealthCare Technologies, and other prominent sector participants.

Key Takeaways for Decision-Makers

  • Healthcare organizations are moving away from traditional equipment to embrace innovative respiratory technologies that improve patient experiences and deliver reliable insights across the care continuum.
  • Integrated digital platforms and enhanced health record connectivity are key for simplifying patient engagement and elevating efficacy in virtual care and telemedicine.
  • Expanded use of portable and point-of-care diagnostics enables clinicians to make more timely, evidence-informed decisions in various healthcare settings.
  • Regional supplier alliances and investments in local manufacturing capabilities serve to strengthen supply chains and reduce vulnerability to regulatory disruptions or global uncertainties.
  • Manufacturers are adjusting product lines and compliance processes to address evolving regional standards, expediting market entry and maintaining local alignment.
  • Procurement leaders are focusing on risk mitigation, adapting to a broader range of international policies to maintain business continuity across diverse markets.

Tariff Impact on Supply Chains

Anticipated changes in tariffs and trade policies in 2025 are driving manufacturers to implement regional production models and flexible sourcing. By expanding local sourcing strategies and updating contractual terms, organizations can secure timely access to critical respiratory care components. Proactive adaptation is essential for sustaining operational continuity and maintaining responsiveness amid ongoing supply chain volatility.

Methodology & Data Sources

This research adopts a mixed-methods approach by combining primary interviews with stakeholders, in-depth secondary research, and systematic data triangulation. All findings are validated with industry benchmarks to ensure credible, decision-ready insights for healthcare leaders.

Why This Report Matters

  • Empowers senior leaders to adapt investment, operational, and technology strategies with precision as clinical, regulatory, and digital priorities evolve.
  • Provides practical guidance to shape product and supply chain approaches addressing both global opportunities and region-specific challenges.
  • Delivers focused recommendations for adopting segmentation and digital innovation, supporting improvements in patient care outcomes and organizational efficiency.

Conclusion

Breakthroughs in care models, digital adoption, and resilient supply chain practices are redefining the market landscape. Decision-makers can use these insights to steer organizational progress and reinforce market positioning in a rapidly changing sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Integration of smart inhaler platforms with real-time patient adherence monitoring
5.2. Increasing adoption of high-flow nasal cannula therapy for acute respiratory distress management
5.3. Rise of AI-driven home ventilator systems offering predictive respiratory pattern analysis
5.4. Development of antiviral filtration modules in nebulizers to curb airborne pathogen spread
5.5. Expansion of telehealth integrated CPAP and BiPAP devices for remote patient monitoring
5.6. Surge in demand for eco-friendly disposable respiratory masks with biodegradable materials
5.7. Stringent cybersecurity regulations driving design changes in connected respiratory devices architecture
5.8. Closed-loop oxygen therapy with automated FiO2 titration integrated into bedside monitors to reduce hypoxemia
5.9. Transition from jet to mesh nebulizers in hospitals to enhnace drug deposition, shorten treatment times
5.10. EU MDR and UKCA compliance demands elevating clinical evidence generation for respiratory care devices
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Respiratory Care Devices Market, by Product Type
8.1. Consumables & Accessories
8.1.1. Breathing Circuits
8.1.2. Masks
8.1.3. Nasal Cannulas
8.1.4. Tracheostomy Tubes
8.2. Diagnostic Devices
8.2.1. Peak Flow Meters
8.2.2. Polysomnography Devices
8.2.3. Spirometers
8.3. Monitoring Devices
8.3.1. Capnographs
8.3.2. Pulse Oximeters
8.4. Therapeutic Devices
8.4.1. Humidifiers
8.4.2. Nebulizers
8.4.3. Oxygen Concentrators
8.4.4. Positive Airway Pressure Devices
9. Respiratory Care Devices Market, by Patient Group
9.1. Adult
9.2. Geriatric
9.3. Neonatal
9.4. Pediatric
10. Respiratory Care Devices Market, by Indication
10.1. Acute Respiratory Distress Syndrome
10.2. Asthma
10.3. Chronic Obstructive Pulmonary Disease
10.4. Sleep Apnea
11. Respiratory Care Devices Market, by Sales Channel
11.1. Offline Sales
11.2. Online Sales
12. Respiratory Care Devices Market, by End User
12.1. Ambulatory Care Centers
12.2. Diagnostic Centers
12.3. Homecare Settings
12.4. Hospitals & Clinics
13. Respiratory Care Devices Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Respiratory Care Devices Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Respiratory Care Devices Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. ResMed Corp.
16.3.2. Baxter International, Inc.
16.3.3. Allied Medical LLC
16.3.4. Catalent, Inc.
16.3.5. Getinge AB
16.3.6. Hamilton Medical AG
16.3.7. Invacare Corporation
16.3.8. Koninklijke Philips N.V.
16.3.9. Medtronic PLC
16.3.10. Omron Corporation
16.3.11. Schiller AG
16.3.12. Smiths Group PLC
16.3.13. Teleflex Incorporated
16.3.14. Thermo Fisher Scientific Inc.
16.3.15. Drägerwerk AG & Co. KGaA
16.3.16. Fisher & Paykel Healthcare Limited
16.3.17. GE HealthCare Technologies Inc.
16.3.18. L’Air Liquide S.A.
16.3.19. Masimo Corporation
16.3.20. Max Ventilator Pvt. Ltd.
16.3.21. Medline Industries, LP
16.3.22. Nihon Kohden Corporation
16.3.23. Nonin Medical, Inc.
16.3.24. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
16.3.25. Löwenstein Medical SE & Co. KG
16.3.26. WEINMANN Emergency Medical Technology GmbH + Co. KG

Companies Mentioned

The companies profiled in this Respiratory Care Devices market report include:
  • ResMed Corp.
  • Baxter International, Inc.
  • Allied Medical LLC
  • Catalent, Inc.
  • Getinge AB
  • Hamilton Medical AG
  • Invacare Corporation
  • Koninklijke Philips N.V.
  • Medtronic PLC
  • Omron Corporation
  • Schiller AG
  • Smiths Group PLC
  • Teleflex Incorporated
  • Thermo Fisher Scientific Inc.
  • Drägerwerk AG & Co. KGaA
  • Fisher & Paykel Healthcare Limited
  • GE HealthCare Technologies Inc.
  • L’Air Liquide S.A.
  • Masimo Corporation
  • Max Ventilator Pvt. Ltd.
  • Medline Industries, LP
  • Nihon Kohden Corporation
  • Nonin Medical, Inc.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Löwenstein Medical SE & Co. KG
  • WEINMANN Emergency Medical Technology GmbH + Co. KG

Table Information